Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M12,270Revenue (TTM) $M4,464Net Margin (%)13.5Altman Z-Score2.4
Enterprise Value $M15,165EPS (TTM) $0.9Operating Margin %23.2Piotroski F-Score5
P/E(ttm)27.2Beneish M-Score-2.1Pre-tax Margin (%)17.6Higher ROA y-yN
Price/Book4.010-y EBITDA Growth Rate %--Quick Ratio1.4Cash flow > EarningsY
Price/Sales3.75-y EBITDA Growth Rate %20.9Current Ratio2.9Lower Leverage y-yY
Price/Free Cash Flow57.4y-y EBITDA Growth Rate %3.5ROA % (ttm)5.7Higher Current Ratio y-yN
Dividend Yield %2.0PEG1.3ROE % (ttm)15.8Less Shares Outstanding y-yY
Payout Ratio %41.0Shares Outstanding M683ROIC % (ttm)13.5Gross Margin Increase y-yN

Gurus Latest Trades with GRFS

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

GRFS is held by these investors:

GRFS: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about GRFS:

    News about GRFS:

    Articles On GuruFocus.com
    John Paulson's Largest 3rd Quarter Trades Dec 01 2016 
    John Paulson Raises Stake in Valeant, Teva Pharmaceutical Mar 18 2016 
    Gold-Focused Guru John Paulson Reports First Quarter Holdings May 22 2014 
    Is Grifols Being Overlooked? Mar 19 2014 
    John Paulson's Top Five Holdings Nov 20 2013 
    John Paulson's Top Five Holdings Sep 12 2013 
    Baron Funds Comments on Grifols SA Aug 30 2012 
    Friday Value Overview Aug 19 2011 

    More From Other Websites
    Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod Mar 21 2017
    AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal Mar 20 2017
    Is Grifols a Great Stock for Value Investors? Mar 17 2017
    New Strong Buy Stocks for March 9th Mar 09 2017
    Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 8.6% Mar 09 2017
    5 European Stocks to Buy as Trump Rally Weakens Mar 07 2017
    Grifols SA :GRFS-US: Earnings Analysis: 2016 By the Numbers : March 6, 2017 Mar 06 2017
    Grifols SA :GRFS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017 Mar 03 2017
    Blog Coverage Kite Pharma CAR-T Cancer Therapy Demonstrate Positive Results in B-cell non-Hodgkin... Mar 02 2017
    Grifols closes the acquisition of Hologic's share of NAT donor screening unit for USD 1,850 million Jan 31 2017
    Hologic Completes Divestiture of Blood Screening Business Jan 31 2017
    Grifols SA : GRFS-US: Dividend Analysis : December 07th, 2016 (record date) : By the numbers :... Jan 30 2017
    Grifols, S.A. upgraded by JP Morgan Jan 03 2017
    Hologic (HOLX) to Divest Blood Screening Business to Grifols Dec 19 2016
    Hologic Still A Buy After Getting 'Lofty' Price For Blood-Screening Unit Dec 15 2016
    Hologic Agrees to Sell Blood Screening Business to Grifols for $1.85B Dec 14 2016
    Grifols to buy Hologic's stake in blood screening JV for $1.85 billion Dec 14 2016
    Grifols agrees to acquire Hologic's share of NAT donor screening unit for USD 1,850 million Dec 14 2016
    Hologic to Divest Blood Screening Business to Partner Grifols for $1.85 Billion Dec 14 2016
    ETFs with exposure to Grifols SA : December 13, 2016 Dec 13 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)